ABT NYSE Week ended 31 Jul 2026

Weekly Investor Report

Abbott Laboratories · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 105.7 USD
2.6% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is 5.2% above the Trend Line and sits at 44.5% of its 52-week range. The latest completed week returned 2.6%, after a 11.6% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers. Options positioning is bullish with 34/100 conviction, while the latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal; earnings are due in 74d.

Setup score 45 out of 100
Latest Close 105.7 USD 31 Jul 2026
1W Return 2.6% latest completed week
4W Return 11.6% short-term follow-through
12W Return 25.4% quarterly tape
Trend Breadth 19.2% 10 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.6% Latest completed week; four-week move 11.6%. Indicator stack 11/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bullish 34/100 conviction; expected move 1.7%. News sentiment 54/100 53 relevant articles in the latest sentiment read. Event risk 74d Next report is scheduled for 14 Oct 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is 5.2% above the Trend Line and sits at 44.5% of its 52-week range. The latest completed week returned 2.6%, after a 11.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1312-week average 0.03

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.13Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 11.6% over four weeks, 25.4% over 12 weeks, and -15.6% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W2.6%
4W11.6%
12W25.4%
26W-2.7%
52W-15.6%
Active trend streak0 weeks
Active weeks in one year10
Trend breadth19.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.96Latest activity-pressure read.
Pressure change11396.0%Four-week change in activity pressure.
Leadership-13.98Latest relative-leadership reading.
RS change44.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Jun 2026 Field coverage 97% Model confidence 97%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength15/100Blend of value, momentum, and quality. Underlying universe rank 86; rank 1 is best.
Value13/100Relative valuation strength. Underlying universe rank 88; rank 1 is best.
Quality84/100Profitability and accounting quality. Underlying universe rank 17; rank 1 is best.
Momentum17/100Medium-term price momentum. Underlying universe rank 84; rank 1 is best.
Growth11/100Revenue and earnings growth. Underlying universe rank 90; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework37/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
33.1x
Price divided by trailing earnings.
Price / sales
3.9x
Market value relative to trailing revenue.
EV / EBITDA
20.9x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
56.8%
Gross profit retained from each unit of revenue.
Operating margin
17.2%
Operating profit retained from revenue.
Free-cash-flow margin
25.2%
Free cash flow generated from revenue.
Return on invested capital
7.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
8.1%
Latest one-year revenue growth.
EPS growth
-61.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.4%
Cash dividends relative to market value.
Buyback yield
0.3%
Net share repurchases relative to market value.
Shareholder yield
2.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

ABT shows bullish options pressure with a 34/100 conviction score, put-call volume ratio of 0.63, expected move of 1.7%, and Sharemaestro trend signal inactive.

Conviction34/100
Expected move1.7%
Put/call volume0.63
Pressure26
Speculation41
Volatility30
Trend agreement44
Open options detail
Insider activity18 / 2

18 acquisitions and 2 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 53 relevant articles.

13 positive · 37 neutral · 3 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings74dNext report is scheduled for 14 Oct 2026; event risk rises as the date approaches.
Options expected move1.7%Nearest-chain priced movement where available.
52-week drawdown-21.9%Distance below the 52-week high.
13-week volatility3.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+7.9%Week of 17 Jul.
Worst week-5.9%Week of 24 Apr.
Latest week+2.6%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains9
Flat weeks0
Modest losses11
Sharp losses3
Recent vol3.9%13-week weekly-return volatility.
Base vol3.3%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew2.3% / -2.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape37/100

Trend, activity pressure, participation, and risk combine to a 37/100 tape read.

 Indicator analysis18/100

Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 0/12.

Activity pressure 0.13; No reversal markers Factors32/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 38 SVQF37/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 639.5 of 1013 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options51/100

ABT shows bullish options pressure with a 34/100 conviction score, put-call volume ratio of 0.63, expected move of 1.7%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 1.7% Sentiment54/100

Weighted news tone is neutral across 53 relevant articles.

Freenome went public for $300 million, then scored a huge victory with colorectal cancer test Insiders18 / 2

18 acquisitions and 2 disposals in the latest 180-day insider tape.

 Earnings74d

Next report is scheduled for 14 Oct 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026105.7 USD2.6%100.4 USD111.1 USD0.96-13.9854.2MOff
24 Jul 2026103.1 USD2.4%101.0 USD111.1 USD0.83-15.8256.6MOff
17 Jul 2026100.7 USD7.9%101.7 USD111.1 USD0.77-18.7993.3MOff
10 Jul 202693.27 USD-1.5%102.5 USD111.2 USD0.37-26.4550.9MOff
3 Jul 202694.73 USD1.4%103.5 USD111.2 USD-0.01-25.0144.9MOff
26 Jun 202693.46 USD6.5%104.5 USD111.3 USD-0.44-25.1570.0MOff
19 Jun 202687.79 USD0.3%105.6 USD111.3 USD-1.01-32.0378.7MOff
12 Jun 202687.56 USD-3.9%106.9 USD111.4 USD-1.32-32.3668.1MOff
5 Jun 202691.07 USD6.4%108.3 USD111.5 USD-1.41-30.0857.4MOff
29 May 202685.60 USD-2.1%109.4 USD111.5 USD-1.44-36.6052.4MOff
22 May 202687.41 USD3.5%110.6 USD111.6 USD-1.34-35.0949.8MOff
15 May 202684.47 USD0.2%111.9 USD111.7 USD-1.31-37.4468.9MOff
8 May 202684.32 USD-5.7%113.3 USD111.8 USD-1.29-38.1468.6MOff
1 May 202689.46 USD-1.8%114.8 USD111.9 USD-1.31-33.6568.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.